![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Bayer Sues Lupin Over Natazia Patent
Bayer Sues Lupin Over Natazia Patent
January 2, 2013
Bayer is suing Lupin for infringing a patent on birth control drug Natazia. The brand-drug maker alleges Lupin plans to offer its generic Natazia (estradiol valerate and estradiol valerate/dienogest) before the drug loses patent protection in 2026. Natazia was approved in 2010 as an oral contraceptive and to treat pathologically heavy menstruation.
Generic Line
Generic Line
Upcoming Events
-
21Oct